Purchase disclosed
Brian S. Posner
Director
Common Stock
- Reported value
- $40K
- Reported price
- $16.00 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Dyne Therapeutics, Inc.
Last 30 daysInsiders bought $40K · 1 buyer, led by Brian S. Posner (Director) with $40K. Sales: $247.78K by 3 insiders.
Showing the first 6 of 126 trades on this page.
Director
Common Stock
Chief Commercial Officer
Common Stock
Chief Commercial Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
CEO & President
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Chief Commercial Officer
Common Stock
Chief Medical Officer
Common Stock
CEO & President
Common Stock
Chief Financial Officer
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Chief Financial Officer
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Common Stock
Chief Medical Officer
Common Stock
Chief Commercial Officer
Common Stock
CEO & President
Common Stock
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Chief Commercial Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Financial Officer
Common Stock
CEO & President
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Chief Financial Officer
Common Stock
Director
Common Stock
Excluded from the common-share buying signal. See trade details.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockPurchase | 2,500$16.00 / share | $40K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Chief Commercial Officer | Common StockSale10b5-1 | 900$24.35 / share | $21.92K | Sep 4Filed Sep 8 · 4d later | SEC filing |
| Chief Commercial Officer | Common StockSale10b5-1 | 185$18.88 / share | $3.49K | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 3,745$24.35 / share | $91.19K | Sep 4Filed Sep 8 · 4d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 1,290$18.88 / share | $24.36K | Sep 8Filed Sep 8 · 0d later | SEC filing |
| CEO & President | Common StockSale10b5-1 | 5,658$18.88 / share | $106.82K | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Director | Common StockSale10b5-13 trades | 426,412avg $26.20 / share | $11.17M | Aug 13Filed Aug 17 · 4d later | 3 filings
|
| Director | Common StockSale10b5-13 trades | 2,160,516avg $25.00 / share | $54.01M | Aug 14Filed Aug 17 · 3d later | 3 filings
|
| Chief Commercial Officer | Common StockSale10b5-1 | 226$26.28 / share | $5.94K | Aug 13Filed Aug 17 · 4d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 1,556$26.28 / share | $40.89K | Aug 13Filed Aug 17 · 4d later | SEC filing |
| CEO & President | Common StockSale10b5-1 | 4,986$26.28 / share | $131.03K | Aug 13Filed Aug 17 · 4d later | SEC filing |
| Chief Financial Officer | Common StockSale10b5-1 | 1,797$26.28 / share | $47.23K | Aug 13Filed Aug 17 · 4d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 261,460avg $25.51 / share | $6.67M | Jul 27Filed Jul 29 · 2d later | 2 filings
|
| Director | Common StockSale10b5-13 trades | 480,240avg $22.79 / share | $10.94M | Jul 6Filed Jul 8 · 2d later | 3 filings
|
| Director | Common StockSale10b5-17 trades | 297,211avg $23.26 / share | $6.91M | Jul 7Filed Jul 8 · 1d later | 7 filings
|
| Director | Common StockSale10b5-13 trades | 309,268avg $21.28 / share | $6.58M | Jun 26Filed Jun 30 · 4d later | 3 filings
|
| Director | Common StockSale10b5-13 trades | 195,427avg $21.14 / share | $4.13M | Jun 29Filed Jun 30 · 1d later | 3 filings
|
| Chief Financial Officer | Common StockSale | 2,362$20.37 / share | $48.11K | Jun 25Filed Jun 26 · 1d later | SEC filing |
| Director | Common StockSale10b5-13 trades | 147,760avg $21.13 / share | $3.12M | Jun 23Filed Jun 26 · 3d later | 3 filings
|
| Director | Common StockSale10b5-13 trades | 95,900avg $21.02 / share | $2.02M | Jun 24Filed Jun 26 · 2d later | 3 filings
|
| Director | Common StockSale10b5-13 trades | 24,100avg $21.10 / share | $508.51K | Jun 25Filed Jun 26 · 1d later | 3 filings
|
| Director | Common StockSale10b5-1 | 190,676$20.57 / share | $3.92M | Jun 22Filed Jun 24 · 2d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 73,286avg $21.05 / share | $1.54M | Jun 23Filed Jun 24 · 1d later | 2 filings
|
| Director | Stock option (right to buy)Grant or award | Derivative units57,463Award · no purchase price | Non-cash award | Jun 22Filed Jun 23 · 1d later | SEC filing |
| Director | Common StockSale10b5-1 | 37,454$20.14 / share | $754.32K | Jun 17Filed Jun 22 · 5d later | SEC filing |
| Director | Common StockSale10b5-1 | 46,901$20.07 / share | $941.37K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 887$18.33 / share | $16.26K | Jun 16Filed Jun 17 · 1d later | SEC filing |
| Chief Commercial Officer | Common StockSale10b5-1 | 145$18.33 / share | $2.66K | Jun 16Filed Jun 17 · 1d later | SEC filing |
| CEO & President | Common StockSale10b5-1 | 2,683$18.33 / share | $49.18K | Jun 16Filed Jun 17 · 1d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Common StockPurchase | 2,000$16.94 / share | $33.88K | Jun 8Filed Jun 9 · 1d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Common StockPurchase | 2,500$17.48 / share | $43.7K | Jun 3Filed Jun 5 · 2d later | SEC filing |
| Director | Common StockPurchase | 2,000$18.21 / share | $36.42K | May 26Filed May 28 · 2d later | SEC filing |
| Director | Common StockPurchase | 2,500$17.12 / share | $42.8K | May 20Filed May 22 · 2d later | SEC filing |
| Chief Commercial Officer | Common StockSale10b5-1 | 228$18.36 / share | $4.19K | May 13Filed May 14 · 1d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 1,564$18.36 / share | $28.72K | May 13Filed May 14 · 1d later | SEC filing |
| Chief Financial Officer | Common StockSale10b5-1 | 1,448$18.36 / share | $26.59K | May 13Filed May 14 · 1d later | SEC filing |
| CEO & President | Common StockSale10b5-1 | 3,311$18.36 / share | $60.79K | May 13Filed May 14 · 1d later | SEC filing |
| Director | Common StockSale10b5-14 trades | 11,904avg $18.00 / share | $214.27K | May 4Filed May 6 · 2d later | 4 filings
|
| Director | Common StockSale10b5-14 trades | 11,600avg $18.03 / share | $209.15K | May 5Filed May 6 · 1d later | 4 filings
|
| Director | Common StockSale10b5-14 trades | 83,219avg $18.18 / share | $1.51M | May 6Filed May 6 · 0d later | 4 filings
|
| Director | Common StockSale10b5-18 trades | 227,337avg $18.38 / share | $4.18M | Apr 28Filed Apr 30 · 2d later | 8 filings
|
| Director | Common StockGift | 53,625Gift · no purchase price | Not a purchase | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockSale10b5-14 trades | 73,108avg $19.19 / share | $1.4M | Apr 23Filed Apr 27 · 4d later | 4 filings
|
| Director | Common StockSale10b5-14 trades | 137,948avg $18.48 / share | $2.55M | Apr 24Filed Apr 27 · 3d later | 4 filings
|
| Director | Common StockSale10b5-14 trades | 173,493avg $18.15 / share | $3.15M | Apr 27Filed Apr 27 · 0d later | 4 filings
|
| Director | Common StockSale10b5-1 | 8,300$20.01 / share | $166.12K | Apr 21Filed Apr 23 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 2,652$20.00 / share | $53.05K | Apr 22Filed Apr 23 · 1d later | SEC filing |
| Director | Common StockSale10b5-14 trades | 272,049avg $20.06 / share | $5.46M | Apr 20Filed Apr 22 · 2d later | 4 filings
|
| Director | Common StockSale10b5-18 trades | 274,297avg $19.52 / share | $5.35M | Apr 21Filed Apr 22 · 1d later | 8 filings
|
| Director | Common StockSale10b5-14 trades | 287,956avg $19.68 / share | $5.67M | Apr 22Filed Apr 22 · 0d later | 4 filings
|
| Director | Common StockSale10b5-1 | 211,974$20.29 / share | $4.3M | Apr 17Filed Apr 21 · 4d later | SEC filing |
| Director | Common StockSale10b5-1 | 125,274$20.07 / share | $2.51M | Apr 20Filed Apr 21 · 1d later | SEC filing |
| Director | Common StockSale10b5-1 | 81,840$20.27 / share | $1.66M | Apr 15Filed Apr 17 · 2d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 17,773avg $20.71 / share | $368.11K | Apr 16Filed Apr 17 · 1d later | 2 filings
|
| Chief Financial Officer | Common StockSale10b5-1 | 5,727$18.64 / share | $106.75K | Apr 1Filed Apr 3 · 2d later | SEC filing |
| Director | Common StockPurchaseExcluded from purchase score | 2,000$17.08 / share | $34.16K | Mar 30Filed Apr 1 · 2d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
$79,200 of common-equity purchase value after transaction-age decay across 180 days.
1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.